Testosterone prescribing skyrockets

The world is in the midst of a multi-billion-dollar “epidemic of unproven, unjustified testosterone prescribing”, an Australian expert says.

A combination of poorly defined expert guidance and pharmaceutical company marketing has led to huge surges in off-label prescribing of the hormone, according to Professor David Handelsman.

In a new study, he showed global testosterone sales have soared 12-fold, from $150 million in 2000 to $1

Latest

Trending